Is Mounjaro for Diabetes?

Mounjaro contains the active substance tirzepatide, which acts on two receptor pathways: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual action is what distinguishes it from medicines like Wegovy (semaglutide), which targets GLP-1 alone. To understand the broader picture of how these mechanisms work, the page on how Mounjaro works covers the science in more detail.

In type 2 diabetes, blood sugar regulation is impaired. GLP-1 receptor agonists help the body release insulin in response to food and reduce the amount of glucose released by the liver — effects that support blood sugar management. Because tirzepatide also activates the GIP pathway, it has a combined influence on both insulin secretion and appetite regulation.

It is worth understanding that Mounjaro is not insulin — it works differently from insulin and belongs to a separate class of medicines entirely. Whether it is appropriate for any individual with diabetes, and at what dose, is a clinical decision made by a prescriber. This page does not provide dosing guidance; those decisions belong with your healthcare professional.

People sometimes ask about Wegovy and diabetes too. Wegovy (semaglutide) also acts on GLP-1 receptors and has been studied in people with type 2 diabetes, though its licensed indication in many countries is primarily weight management. Again, your prescriber is the right person to discuss which medicine is appropriate for you.

For a broader overview of what this medicine is and how it is used, the page what Mounjaro is provides useful background context.

According to NHS guidance, tirzepatide is a prescription-only medicine and its suitability — including for people with type 2 diabetes — depends on an individual's full medical history and other factors assessed by a clinician.

Whether you have been prescribed Mounjaro for type 2 diabetes, weight management, or both, keeping a clear record of your experience matters. GLP Trackr's dose logging feature lets you record every injection — including the dose strength, date, and time — so you always have an accurate history to refer to or share with your prescriber at appointments.

Because Mounjaro is a once-weekly injection, it can be easy to lose track of where you are in your schedule. GLP Trackr's dose reminders help you stay consistent, and the built-in injection-site rotation tracker logs which site you used last and suggests where to inject next — useful for maintaining good rotation practice over time.

If you notice anything worth discussing with your healthcare professional — whether that is a side effect, a change in energy levels, or something else — logging it in the app means you have a clear, timestamped record ready for that conversation. GLP Trackr is a companion for your journey; it is not a substitute for the clinical guidance your prescriber provides.

Any questions about your dose, your diabetes management, or whether Mounjaro is right for you should always go to your prescriber or doctor — they know your full history and are best placed to advise you. If you experience anything severe, persistent, or worrying, contact your healthcare professional promptly.

To explore more about how Mounjaro works and what to expect, visit the Mounjaro: how it works hub.

Log your doses, track your injection sites, and keep your journey in one place — GLP Trackr is free to try for 7 days on the App Store and Google Play.